Welcome to the e-CCO Library Archive!
E. Corazziari1, N. Pallotta1, G. Vincoli1, D. Piacentino2, 1La Sapienza, Medicina Interna e Specialità Mediche, Rome, Italy, 2Università Sapienza, Neurologia e Psichiatria, Rome, Italy
Outcomes of a large cohort of children with IBDU compared to other IBD subtypes and treatment options- a longitudinal report from the Porto pediatric IBD group of ESPGHAN
M. Aloi1, L. Birimberg-Schwartz2, I. Hojsak3, S. Buderus4, A. Paerregaard5, J. Bronsky6, J. Fell7, S. Koletzko8, G. Veereman9, R. Shaoul10, E. Miele11, D. Turner2, R. Russell*12
1Sapienza University of Rome, Pediatrics, Rome, Italy, 2Shaare Zedek Medical Center, Department of Pediatrics, Jerusalem, Israel, 3Clinical Hospital Center Sestre Milosrdnice, Department of Pediatrics, Zabreb, Croatia, 4Marien Hospital, Department of Pediatrics, Bonn, Germany, 5Hvidovre Hospital, Department of Pediatrics, Hvidovre, Denmark, 6Charles University Prague, Department of Pediatrics, Prague, Czech Republic, 7Chelsea and Westminster Hospital, Paediatric Gastroenterology, London, United Kingdom, 8Helmholtz Zentrum Munchen, Department of Pediatrics, Munich, Germany, 9Uz Brussel, Department of Pediatrics, Bruxelles, Belgium, 10Rambam Medical Center, Department of Pediatrics, Haifa, Israel, 11Federico II University, Department of Pediatrics, Naples, Italy, 12York Hill Hospital, Department of Pediatrics, Glasgow, United Kingdom
Inflammatory bowel disease and compliance with the Mediterranean diet
V. Teixeira1, S. Velho1, J. Torres2, L. Glória2, 1Hospital Beatriz Ângelo, Serviço de Dietética e Nutrição, Lisboa, Portugal, 2Hospital Beatriz Ângelo, Serviço de Gastrenterologia, Lisboa, Portugal
L.S. Kiss1, B.D. Lovasz1, P.A. Golovics1, Z. Vegh1, K. Farkas2, T. Molnar2, K. Palatka3, A. Mohas1, B.K. Szilagyi1, S.A. Fekete1, P. Lakatos1, 1Semmelweis University, 1st Department of Medicine, Budapest, Hungary, 2Szeged, 1st Department of Medicine, Szeged, Hungary, 3University of Debrecen, 2nd Department of Medicine, Debrecen, Hungary
Contrast-enhanced ultrasonography in the evaluation of Crohn's disease activity: correlation with ileocolonoscopy
F. Dias de Castro*1, J. Magalhães1, P. Boal Carvalho1, M.J. Moreira1, S. Leite1, J. Cotter1, 2, 3
1Centro Hospitalar do Alto Ave, Gastroenterology, Guimaraes, Portugal, 2School of Health Sciences, University of Minho, Life and Health Sciences Research Institute (ICVS), Braga, Portugal, 3PT Government Associate Laboratory, ICVS/3B’s, Braga/Guimarães, Portugal
Inflammatory joint- and bowel diseases – a clinical proteomics study seeking to identify the underlying biological triggers
T. Bennike1, T. Gelsing Carlsen1, L. Sennels1, K.B. Lauridsen1, H. Glerup2, O.K. Bonderup2, T.J. Ellingsen2, L. Vogel3, V. Andersen4, S. Birkelund1, A. Stensballe1, 1Aalborg University, Department of Health Science and Technology, Aalborg East, Denmark, 2Regional Hospital Silkeborg, Diagnostic Center, Section of Gastroenterology, Silkeborg, Denmark, 3Copenhagen University, Department of Molecular and Cellular Medicine, Copenhagen, Denmark, 4University of Southern Denmark, Institute for Regional Health Research, Odense, Denmark
M.L. Annunziata1, P. Balestrieri1, I. Sansoni2, C. Coluccio1, R. Del Vescovo2, A. Tullio1, B. Beomonte Zobel2, A. Armuzzi3, M. Cicala1, 1Campus Bio-Medico University, Digestive Disease Department, Rome, Italy, 2Campus Bio-Medico University, Diagnostic Imaging Department, Rome, Italy, 3Complesso Integrato Columbus, Unit of Internal Medicine and Gastroenterology, Rome, Italy
Small bowel mucosal healing and deep remission in patients with known small bowel Crohn's disease.
U. Kopylov*1, D. Yablecovitch2, A. Lahat2, S. Neuman2, N. Levhar2, E. Klang3, M.M. Amitai3, S. Ben-Horin2, R. Eliakim2
1Sheba Medical Center, Gastroenterology, Tel Hashomer, Israel, 2Chaim Sheba Medical Center, Gastroenterology, Ramat Gan, Israel, 3Sheba Medical Center, Department of Diagnostic Imaging, Tel Hashomer, Israel
Indicators of inadequate response to biologic therapies in patients with Crohn's disease from real-world practice settings
H.T. Hatoum1,2, H. Patel3, S.-J. Lin1,2, R. Mody3, 1Hind T. Hatoum and Company, Consulting, Chicago, United States, 2University of Illinois at Chicago, Department of Pharmacy Systems, Outcomes and Policy, Chicago, United States, 3Takeda Pharmaceuticals International, Inc., Global Outcomes and Epidemiology Research, Deerfield, United States
C. Menezes1, R. Rocha1, F. Coqueiro1, M. Lopes1, P. Nunes1, L. Sales1, C. Factum1, N. Almeida2, G. Santana2, B. César da Silva2, 1Universidade Federal da Bahia, Nutrição, Salvador, Brazil, 2Universidade Federal da Bahia, Gastroenterologia, Salvador, Brazil
Ionizing radiation throughout the duration of immunosuppression therapy in Crohn's disease: should it remain a concern?
R. Coelho*1, F. Magro1, L. S. Guimarães2, M. Silva1, A. Peixoto1, S. Lopes1, G. Macedo1
1Centro Hospitalar São João, Gastrenterology, Porto, Portugal, 2Centro Hospitalar São João, Radiology, Porto., Portugal
Indicators of inadequate response to anti-tumour necrosis factor therapies in patients with ulcerative colitis from real-world practice settings
H.T. Hatoum1,2, H. Patel3, S.-J. Lin1,2, R. Mody3, 1Hind T. Hatoum and Company, Consulting, Chicago, United States, 2University of Illinois at Chicago, Department of Pharmacy Systems, Outcomes and Policy, Chicago, United States, 3Takeda Pharmaceuticals International, Inc., Global Outcomes and Epidemiology Research, Deerfield, United States